Li Sun

A Multinational, Randomized, Open-label, Treat-to-Target Trial Comparing Insulin Degludec and Insulin Glargine in Insulin-Naïve Patients with Type 2 Diabetes Mellitus

R. Wagner, Wenying Yang, J. Gross, 2016, Drugs in R&D.

The SEED study of dorzagliatin in drug-naïve patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, phase 3 trial

L. Shi, G. Qin, Guixia Wang, 2021 .

Dorzagliatin in drug-naïve patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial

P. Li, L. Shi, Xuefeng Yu, 2022, Nature Medicine.

Comparative efficacy and safety of two insulin aspart formulations (Rapilin and NovoRapid) when combined with metformin, for patients with diabetes mellitus: a multicenter, randomized, open-label, controlled clinical trial

Xuefeng Yu, Quanmin Li, Yongde Peng, 2022, Current medical research and opinion.

Polyethylene glycol loxenatide injections added to metformin effectively improve glycemic control and exhibit favorable safety in type 2 diabetic patients

Gangyi Yang, Jin-kui Yang, Yongde Peng, 2017, Journal of diabetes.